Q4 2023 update: microbiome related M&A activity in the pharmaceutical industry
In the global pharmaceutical industry, there were 3 M&A deals announced in Q4 2023, worth a total value of $511.6m, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: cybersecurity related M&A activity in the pharmaceutical...
In the global pharmaceutical industry, there were 2 M&A deals announced in Q4 2023, worth a total value of $54.2m, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: mobile health related M&A activity in the pharmaceutical...
In the global pharmaceutical industry, there were 4 M&A deals announced in Q4 2023, worth a total value of $32.6m, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: electronic medical record (emr) systems related M&A activity...
In the global pharmaceutical industry, there were 2 M&A deals announced in Q4 2023, worth a total value of $36m, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: remote patient monitoring related M&A activity in the...
In the global pharmaceutical industry, there were 3 M&A deals announced in Q4 2023, worth a total value of $23.1m, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: easy & affordable related M&A activity in the pharmaceutical...
In the global pharmaceutical industry, there were 3 M&A deals announced in Q4 2023, worth a total value of $7.3m, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: cloud related M&A activity in the pharmaceutical industry
In the global pharmaceutical industry, there were 3 M&A deals announced in Q4 2023, worth a total value of $54.2m, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: energy transition related M&A activity in the pharmaceutical...
In the global pharmaceutical industry, there were 3 M&A deals announced in Q4 2023, worth a total value of $161.4m, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: renewable energy related M&A activity in the pharmaceutical...
In the global pharmaceutical industry, there were 2 M&A deals announced in Q4 2023, worth a total value of $161.4m, according to GlobalData's Deals Database.
View ArticleQ4 2023 update: immuno-oncology related M&A activity in the pharmaceutical...
In the global pharmaceutical industry, there were 14 M&A deals announced in Q4 2023, worth a total value of $1.9bn, according to GlobalData's Deals Database.
View Article
